Where it all began – why we developed The Experience Gap
June 1, 2026 | Participant engagement, clinical trials, communication
Learn how The Experience Gap was developed to help sponsors, CROs and site teams improve clinical trial participation by identifying friction points, enhancing patient experience, and driving better recruitment and retention outcomes.
When we launched The Experience Gap, the response reflected something we hear time and again across the clinical trial community: everyone recognises participation challenges exist, yet turning that understanding into meaningful change remains a real challenge.
There is no shortage of insight. For years, sponsors, sites and patients have been pointing to the same pressures: recruitment is getting harder, retention is fragile, and site burden continues to intensify. Connecting all of these challenges is one defining factor: experience. Because when trial experiences feel fragmented, inconsistent or difficult, participation becomes harder to start – and even harder to sustain.
But insight alone does not drive progress. And that is exactly why we created The Experience Gap.
The foundations for this work began with The Participation Equation – a simple but important shift in perspective. Rather than viewing participation as a single decision point, we saw it as a system shaped by every interaction across the trial journey.
Because participation is influenced by far more than protocol design or recruitment drives. Communication, operational processes, emotional burden, trust and consistency all shape how people experience a trial. Every interaction matters.
That thinking became the lens through which we approached our later research.
Across our first two reports — including The Site Factor — recurring patterns began to emerge. Sponsors were investing heavily in engagement, yet sites were often carrying disproportionate operational and emotional pressure. Patients, meanwhile, were navigating fragmented journeys that rarely felt joined up. Intentions were good, of course, but lived reality frequently looked very different.
Most importantly, these were not isolated findings. The same tensions surfaced repeatedly across conversations, interviews and research. What became clear was that the challenge facing many trial teams was not a lack of awareness, but uncertainty around what to do next.
Teams increasingly recognise that experience matters, but many still struggle to operationalise it. Where should interventions happen? Which moments matter most? How do you prioritise change when resources, timelines and delivery pressures are already stretched?
That gap between understanding and action is what The Experience Gap was designed to address.
From the outset, the aim was to create more than a research report. We wanted to build a practical roadmap that could help teams identify participation friction, prioritise improvements and make more confident decisions across the trial journey.
The roadmap is grounded in lived experience and informed by the realities faced by patients, sites and sponsors alike. It is designed to support practical decision-making, while remaining flexible enough to work across different trial types, phases and operational models.
For us, this is where experience work becomes genuinely valuable – when it informs real-world decisions rather than sitting passively as insight alone.
Closing the experience gap requires more than isolated fixes. Participation is shaped across an interconnected ecosystem of patients, sites and sponsors – which means improving outcomes depends on understanding how experiences connect across the entire trial journey.
That is exactly what The Experience Gap was built to support.
Clinical trials are growing more complex. Competition for both patients and sites continues to intensify, while expectations around support, communication and accessibility are rising fast. Experience is no longer a secondary consideration – it is increasingly becoming a defining factor in whether trials succeed.
But improving experience takes more than isolated initiatives or good intentions alone. It requires clear direction, practical frameworks and the ability to translate insight into meaningful action.
That is ultimately why we created The Experience Gap. Not to add more noise to the conversation, but to help teams navigate it more clearly, and to provide a practical starting point for designing better participation experiences across the clinical trial journey.
Explore The Experience Gap roadmap and discover how insight can be turned into action across every stage of participation.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Clinical trial considerations: Why diversity matters…
Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here’s why diversity matters…
Clinical trial considerations: Why digital matters…
Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.
Clinical trials explained: Why imagery matters…
Recruiting patients for clinical trials is one of pharma’s greatest challenges. Imagery is a great way to connect with people on an emotional level and forms a big part the…
Clinical trials explained: Why health literacy matters…
Clinical trial recruitment can be a challenge. By applying the principles of health literacy to all materials, we can support people to make an informed choice about whether to take…
Clinical trials explained: Why iconography matters…
Icons serve as a useful form of alternative communication. We spend a lot of time developing icons for healthcare communications. Find out how we use iconography to elevate clinical trial…
Cuttsy+Cuttsy appoints Harriet Karia as Managing Director
Cuttsy+Cuttsy is pleased to announce the appointment of Harriet Karia as its first Managing Director.
Using generative AI in healthcare comms – our promise to our clients
It’s safe to say one of the hottest topics of 2023 has been ChatGPT and the launch of other Generative AI-driven applications. So, we’re sharing our promises, so that when…
Clinical trials explained: Why colour matters…
Colour can be used to emphasise mood, evoke emotions, and determine first impressions of a brand. Find how to use colour effectively in your next clinical trial campaign.
Clinical trials explained: Why branding matters…
With nearly a decade’s experience supporting clinical trials, find out why we think humanising trials through design is so important.
DPHARM2023 – Five key themes impacting clinical trials today
Throughout three fascinating days of conference, some key themes emerged that are impacting study teams and the effectiveness of their clinical trials on a daily basis.